Livestock mRNA assessment funding provided, report required, and money appropriated.

This bill appropriates $250,000 from the general fund for the Minnesota Commissioner of Agriculture to develop a science-based assessment of mRNA treatments for livestock. The assessment must evaluate risks and benefits, including current commercial use and research trials, and be developed with input from the University of Minnesota Veterinary Medical Center and the Commissioner of Health. The Commissioner must submit a final report with policy recommendations to relevant legislative committees by January 15, 2026. The bill directly affects Minnesota's livestock industry by funding a review of emerging agricultural technologies, though it does not impose new regulations or requirements on farmers.